Study summary

A clinical study to evaluate the efficacy and safety of solifenacin in patients with bladder symptoms due to spinal cord injury or multiple sclerosis

Additional Study Details

Phase
4
Product
N/A
Product
Solifenacin Succinate
Oxybutynin Hydrochloride
Placebo
Type
Interventional
Masking
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
Enrollment number
249
Show Additional Study Details

Study documents

Scientific Results Summary
Available Language(s): English
Plain Language Summary
Available Language(s): English

Get more information

Would you like more information about clinical trial sites that are recruiting participants for Clinical study of solifenacin succinate in patients with bladder symptoms due to spinal cord injury or multiple sclerosis? Contact us by filling out your information to the right and we’ll respond to you.

  • A caregiver
  • A healthcare provider
  • A parent
  • A patient
  • A patient advocate
  • Algeria
  • Argentina
  • Armenia
  • Australia
  • Austria
  • Belarus
  • Belgium
  • Bosnia And Herzegovina
  • Brazil
  • Bulgaria
  • Canada
  • Chile
  • China
  • Colombia
  • Croatia
  • Czech Republic
  • Denmark
  • Dominican Republic
  • Egypt
  • Estonia
  • Finland
  • Former Serbia and Montenegro
  • France
  • Georgia
  • Germany
  • Greece
  • Guatemala
  • Hong Kong
  • Hungary
  • Iceland
  • India
  • Indonesia
  • Ireland
  • Israel
  • Italy
  • Japan
  • Jordan
  • Kazakhstan
  • Latvia
  • Lebanon
  • Lithuania
  • Macedonia
  • Malaysia
  • Mexico
  • Montenegro
  • Morocco
  • Netherlands
  • New Zealand
  • Norway
  • Panama
  • Peru
  • Philippines
  • Poland
  • Portugal
  • Puerto Rico
  • Republic of Korea
  • Republic of Moldova
  • Romania
  • Russian Federation
  • Saudi Arabia
  • Serbia
  • Singapore
  • Slovakia
  • Slovenia
  • South Africa
  • Spain
  • Sweden
  • Switzerland
  • Taiwan, Province of China
  • Thailand
  • Turkey
  • Ukraine
  • United Kingdom
  • United States
  • Vietnam

By clicking ["Continue/Submit"], you agree that Astellas may contact you by email with information to help you connect with clinical trial sites. While we can connect you to clinical trial sites, we cannot answer questions about any investigational therapy through email. Your consent to receiving emails is not a requirement to participate in a clinical trial or study. For more information, including how to unsubscribe at any time, see our Privacy Notice & Cookies Policy.

    Locations

    Contact Us
    Contact Us
    Completed
    Paris, France
    Completed
    Badalona, Barcelona, Spain
    Completed
    St. Petersburg, Russian Federation, 190089
    Completed
    Melbourne, Australia
    Completed
    Gent, Belgium
    Completed
    San Juan de Alicante, Alicante, Spain
    Withdrawn
    Lisboa, Portugal
    Completed
    Nijmegen, Netherlands
    Completed
    Kiel, Germany
    Completed
    Milan, Italy
    Completed
    Brisbane, Australia
    Completed
    Sopron, Hungary
    Completed
    Szeged, Hungary
    Withdrawn
    Tomar, Portugal
    Completed
    Berlin, Germany
    Completed
    Garches, France
    Completed
    Newcastle Upon Tyne, United Kingdom
    Completed
    Caen, France
    Completed
    Firenze, Italy
    Completed
    Nyiregyhaza, Hungary
    Withdrawn
    Porto, Portugal
    Completed
    Prague, Czech Republic
    Completed
    Brno, Czech Republic
    Completed
    Cardiff, United Kingdom
    Completed
    Fraiture-en-Condroz, Belgium
    Completed
    Ploemeur, France
    Completed
    Leuven, Belgium
    Completed
    Getafe, Madrid, Spain
    Completed
    Torino, Italy
    Completed
    Eindhoven, Netherlands
    Completed
    Heidelberg, Germany
    Completed
    Ceske Budejovice, Czech Republic
    Completed
    Randwick, Australia
    Completed
    Esneux, Belgium
    Completed
    Perth, Australia
    Completed
    Hagenow, Germany
    Completed
    Antwerpen, Belgium
    Completed
    Rome, Italy
    Withdrawn
    Norwich, United Kingdom
    Completed
    La Coruna, Spain
    Completed
    St. Petersburg, Russian Federation, 196084
    Completed
    Melsbroek, Belgium
    Completed
    Apeldoorn, Netherlands

    Frequently Asked Questions

    Are clinical trials only for people with advanced cancer?

    While some clinical trials may focus on more advanced cancers, many trials are open to patients at various stages of their cancer. Each study has rules about who can take part. For example, only patients in a certain age group or those who have a certain type of tumor may be able to join.

    Will I have to stop my current treatment to participate in a clinical trial?

    Sometimes researchers want participants to keep taking their current treatments during a clinical trial. Other times, you may need to stop your current treatments for a while. If the investigational treatment doesn't work, you can usually go back to your original treatment plan.

    Should I be worried about getting a placebo?

    In cancer clinical trials, a placebo is only used if there is no other treatment for that type of cancer. This helps compare an investigational treatment to the placebo. Placebos are rarely used in cancer trials because the best available treatment, called the “standard of care”, is usually given instead.

    Do I need a referral from my doctor to take part in a study?

    Your doctor may not know about all the opportunities for clinical trials that are available to you. Talk to your doctor or other medical provider about clinical trial information that you find. They can help you decide if a clinical trial is right for you. If you do not find any options on this website, we recommend you visit an online public registry website like clinicaltrials.gov to see a wide variety of available clinical trials.

    Explore More

    1

    What are clinical trials?

    2

    Why are Clinical Trials Important?

    3

    Why Participate in a Clinical Trial?